55
Kaigene raises $73.35M in biotech capital round under Reg D
Company raise · Raising · ROCKVILLE, MD · Form D filed 2026-10-14
Kaigene, Inc., a Delaware biotech corporation based in Rockville, MD, is raising $73.35M and has sold $54.96M to 22 investors as of September 30, 2026. The offering remains open with $18.39M available under Regulation D exemption 6(b).
$50M+ raiseother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Minjae Shin | Executive Officer, Director |
| Jihoon Park | Executive Officer |
| Kyunghyun Min | Director |
| Tae Heum Jeong | Director |
Signed by Minjae Shin, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.